Neuphoria Therapeutics (NEUP) Stock Price & Financial Analysis
Neuphoria Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Neuphoria Therapeutics
What is the current stock price for NEUP?
As of the latest trading session, NEUP stock trades at $4.41. The 52-week range is $3.65–$21.40, with a day range of $4.07–$4.46.
What is the P/E ratio for NEUP?
The P/E ratio (Price-to-Earnings) for NEUP is shown in the Key Statistics section. This valuation metric helps compare Neuphoria Therapeutics Inc. to industry peers.
Does NEUP pay dividends?
Neuphoria Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for NEUP?
Analyst ratings and recommendations for NEUP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NEUP?
Neuphoria Therapeutics's market capitalization is $20.0M, classifying it as a micro-cap company. Neuphoria Therapeutics operates in the Healthcare sector within the Biotechnology industry.